AIM
SURF

Alambic Investment Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Alambic Investment Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,403
Closed -$83K – 401
2019
Q1 		$83K Sell
17,403
-12,663
-42% -$62.3K 0.03% 325
2018
Q4 		$127K Buy
+30,066
New +$232K 0.05% 269

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alambic Investment Management's SURF Position: Q2 2019 in Review

Alambic Investment Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2019, closing a stake of 17,403 shares — an estimated $83K sold.

Alambic Investment Management first reported a position in SURF in Q4 2018 and held it in 2 quarters. The position peaked at $127K in Q4 2018. 47 funds tracked by Wall St. Rank hold SURF as of Q2 2019.

  • Alambic Investment Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 17,403 Surface Oncology, Inc. Common Stock shares in Q2 2019, an estimated $83K.
  • Alambic Investment Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Alambic Investment Management's Surface Oncology, Inc. Common Stock position peaked at $127K in Q4 2018.
  • 47 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.